Your browser is no longer supported. Please, upgrade your browser.
Settings
PRGO Perrigo Company plc daily Stock Chart
PRGO [NYSE]
Perrigo Company plc
IndexS&P 500 P/E- EPS (ttm)-0.25 Insider Own0.20% Shs Outstand142.88M Perf Week-2.95%
Market Cap13.80B Forward P/E10.20 EPS next Y9.47 Insider Trans-14.73% Shs Float136.59M Perf Month-24.84%
Income-32.80M PEG- EPS next Q1.75 Inst Own78.60% Short Float6.72% Perf Quarter-32.84%
Sales5.35B P/S2.58 EPS this Y-95.80% Inst Trans3.03% Short Ratio3.56 Perf Half Y-38.63%
Book/sh68.93 P/B1.40 EPS next Y10.62% ROA0.40% Target Price132.06 Perf Year-48.42%
Cash/sh3.03 P/C31.90 EPS next 5Y8.65% ROE0.80% 52W Range94.82 - 200.29 Perf YTD-33.16%
Dividend0.58 P/FCF15.44 EPS past 5Y-59.80% ROI0.80% 52W High-51.76% Beta0.26
Dividend %0.60% Quick Ratio0.30 Sales past 5Y0.10% Gross Margin39.50% 52W Low1.89% ATR4.15
Employees13242 Current Ratio0.40 Sales Q/Q36.90% Oper. Margin13.20% RSI (14)19.99 Volatility2.96% 3.24%
OptionableYes Debt/Eq0.60 EPS Q/Q-96.80% Profit Margin1.50% Rel Volume1.39 Prev Close96.11
ShortableYes LT Debt/Eq0.00 EarningsMay 12 BMO Payout96.10% Avg Volume2.58M Price96.61
Recom2.60 SMA20-18.81% SMA50-22.90% SMA200-36.63% Volume3,583,281 Change0.52%
Apr-26-16Reiterated RBC Capital Mkts Sector Perform $140 → $109
Apr-26-16Reiterated Barclays Overweight $180 → $120
Apr-25-16Downgrade Wells Fargo Outperform → Market Perform
Apr-25-16Downgrade BofA/Merrill Buy → Underperform
Feb-22-16Downgrade Goldman Neutral → Sell
Feb-19-16Initiated Wells Fargo Outperform
Feb-19-16Downgrade B. Riley & Co. Buy → Neutral $239 → $146
Jan-21-16Initiated Barclays Overweight $180
Dec-10-15Upgrade Argus Hold → Buy $170
Dec-03-15Initiated Morgan Stanley Equal-Weight
Nov-24-15Reiterated B. Riley & Co. Buy $229 → $237
Nov-18-15Resumed JP Morgan Neutral
Nov-16-15Upgrade UBS Neutral → Buy $200
Oct-23-15Reiterated B. Riley & Co. Neutral $218 → $229
Jun-03-15Reiterated B. Riley & Co. Neutral $195 → $216
Apr-27-15Downgrade B. Riley & Co. Buy → Neutral
Apr-22-15Reiterated B. Riley & Co. Buy $189 → $195
Apr-10-15Downgrade Argus Buy → Hold
Feb-06-15Reiterated RBC Capital Mkts Outperform $177 → $175
Nov-12-14Reiterated Argus Buy $160 → $175
May-03-16 04:17PM  Valeant Pharmaceuticals Intl. Inc. Jumped 27% in April, But It's Not Out of the Woods at Motley Fool
01:55PM  Valeant Shares Spike as New CEO Joseph Papa Takes Office at TheStreet
01:18PM  Valeant (VRX) Stock Soars as Papa Assumes CEO Role at TheStreet
08:53AM  Perrigo And Allergan Announce First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex® 1200mg DM Extended-Release Tablets PR Newswire
02:48AM  Mylan Braces for Continued Generic Drug Price Declines at Bloomberg
May-02-16 04:04PM  The 52-Week Low Club for Monday at 24/7 Wall St.
09:30AM  The Zacks Analyst Blog Highlights: Perrigo Company, Xerox, Apple, DuPont and Boeing Zacks
09:02AM  Perrigo Announces FDA Approval and Launch of the Generic Version of BenzaClin® Pump Topical Gel PR Newswire
May-01-16 02:00PM  It's Scary Down There: Buying at the Lows at TheStreet
Apr-30-16 05:00PM  Short Sellers Target Perrigo After CEO Exit as Goldman Says Sell at Bloomberg
Apr-29-16 10:51AM  Look to the Companies; Chinese Demand Is for Real: Jim Cramer's Best Blogs at TheStreet
Apr-28-16 04:48PM  The 52-Week Low Club for Thursday at 24/7 Wall St.
12:46PM  Heres how much money it took for Perrigos ex-CEO to leave for Valeant at MarketWatch
06:34AM  PERRIGO CO PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
02:00AM  Perrigo Expands the Responsibilities of Sharon Kochan, Perrigo's Executive Vice President and General Manager, International, to Lead the Branded Consumer Healthcare Segment PR Newswire
Apr-27-16 10:14PM  Valeants Michael Pearson Admits Aggressive Drug-Price Increases Were a Mistake at The Wall Street Journal
08:55PM  [$$] Valeant's Pearson Admits Aggressive Drug-Price Increases Were a Mistake at The Wall Street Journal
08:27PM  Valeant Discloses Pay for New CEO at The Wall Street Journal
07:48PM  Valeant to pay new CEO Papa base salary of $1.5 million Reuters
06:21PM  Valeant to pay new CEO Papa base salary of $1.5 mln Reuters
05:02PM  PERRIGO CO PLC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:54PM  Will Joseph Papa Be Able to Change Valeant? Bloomberg
04:04PM  The 52-Week Low Club for Wednesday at 24/7 Wall St.
Apr-26-16 04:23PM  3D Systems Downgraded, GE PT Cut, Disney Gets PT Hike at Investor's Business Daily
04:04PM  The 52-Week Low Club for Tuesday at 24/7 Wall St.
02:34PM  Is There Any Hope for Perrigo Stock? at TheStreet
01:36PM  Perrigo's CEO Resigns, Trims 2016 Outlook, Stock Tumbles Zacks
10:10AM  Stock Market News for April 26, 2016 Zacks
09:43AM  A.M. Funds Roundup: Time To Simplify Your Fund Portfolio? at Barrons.com
09:26AM  Perrigo (PRGO) Stock Falls as Jefferies Downgrades on Guidance Cut at TheStreet
08:55AM  Top Analyst Upgrades and Downgrades: Broadcom, Caterpillar, Sirius XM, Newmont, Palo Alto, Perrigo, Sarepta, Xerox and More at 24/7 Wall St.
08:45AM  Forex Traders Look Past Fed to Bank of Japan at The Wall Street Journal
08:24AM  Perrigo Company plc Announces Quarterly Dividend PR Newswire
07:24AM  Cramer: Papa's Got a Brand New Bag, and Leaves Perrigo Holding the Old One at TheStreet
07:00AM  The Trader Daily: Volatility Cuts Both Ways at TheStreet
05:00AM  New Valeant CEO Papa Trades Challenge at Perrigo for Fresh One at Bloomberg
12:49AM  [$$] Perrigos Pain Isnt Just About Valeant at The Wall Street Journal
12:48AM  [$$] CEO Exits Show That Room at the Top Can Be Lonely at The Wall Street Journal
12:48AM  [$$] As Its CEO Leaves for Valeant, Perrigo Continues to Struggle at The Wall Street Journal
12:47AM  [$$] Valeant Names Joseph Papa as New CEO at The Wall Street Journal
12:15AM  PRESS DIGEST- New York Times business news - April 26 Reuters
Apr-25-16 06:47PM  Cramer: Papa's Got a Brand New Bag, and Leaves Perrigo Holding the Old One at TheStreet -18.09%
06:27PM  Valeant names Papa CEO after he resigns from Perrigo Reuters
05:40PM  Can Papa save Valeant CNBC
05:37PM  Why Perrigo, U.S. Steel, and GoPro Slumped Today at Motley Fool
05:35PM  Embattled drugmaker Valeant taps Papa as new CEO at USA TODAY
05:23PM  PERRIGO CO PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
05:15PM  Stocks End Lower as Earnings Weigh Morningstar
05:06PM  Stocks Quiet Ahead Of Fed; How Will Apple Fare? at Investor's Business Daily
04:54PM  [$$] As Its CEO Leaves for Valeant, Perrigo Continues to Struggle at The Wall Street Journal
04:50PM  US STOCKS-Wall St ends slightly lower on energy, earnings Reuters
04:47PM  Valeant Pharma picks Perrigo leader to become next CEO AP
04:04PM  The 52-Week Low Club for Monday at 24/7 Wall St.
03:47PM  Perrigo Briefly Breaks $100 as Selling Mounts at The Wall Street Journal
03:15PM  VRX vs. PRGO & SRPT vs the FDA CNBC
03:04PM  Valeant Pharma (VRX) Names Former Perrigo (PRGO) CEO to Fill Position Zacks
02:40PM  Dealpolitik: Perrigo CEO Exit Shows Boardroom Can be a Lonely Place at The Wall Street Journal
02:39PM  Stocks rangebound ahead of huge earnings week, Fed meeting Yahoo Finance
01:30PM  Paulson Takes a Hit as Papa Jumps Ship at The Wall Street Journal
01:15PM  Why Joseph Papa Left Perrigo for Valeant Bloomberg
01:15PM  Why Joseph Papa Left Perrigo for Valeant at Bloomberg
01:04PM  More Squawk From Jim Cramer: 'Aghast' at 'Terrible Way' That CEO Papa Left Perrigo (PRGO) at TheStreet
01:00PM  Questions Mount at Valeant, Perrigo Amid Executive Shuffle at TheStreet
12:47PM  Why Perrigo Company PLC Ordinary Shares Are Dropping Today at Motley Fool
12:34PM  [$$] Perrigo's Pain Isn't Just About Valeant at The Wall Street Journal
12:32PM  Monday links: doing more in markets Yahoo Finance Contributors
12:26PM  Perrigo Misses Q1 Views, Cuts Guidance As Valeant Poaches Its CEO at Investor's Business Daily
11:53AM  Valeant Infects Perrigo at Bloomberg
11:48AM  Why These 5 Stocks Are Making Headlines on Monday at Insider Monkey
11:39AM  Perrigo CEO leaves for Valeant; Tribune Publishing soars on bid; Manchester United gains Yahoo Finance
11:35AM  Mylan (MYL) Stock Pressured by Perrigo Profit Warning at TheStreet
11:20AM  Stocks Fall as Earnings Weigh Morningstar
11:15AM  Perrigo's Papa Leaves to Lead Valeant as New CEO Bloomberg
11:14AM  Former Perrigo CEO Joe Papa Will Replace Michael Pearson At Valeant Pharmaceuticals at Forbes
11:03AM  What will they say about you? Yahoo Finance Contributors
10:52AM  US stocks fall in global slump as energy companies skid AP
10:51AM  Perrigo shares tumble as CEO leaves for Valeant, guidance cut again at MarketWatch
10:42AM  Valeant (VRX) Stock Gaining, Names Perrigo's Papa as New CEO at TheStreet
10:40AM  Valeant Names Perrigo's Joseph Papa Chairman and CEO; Shares Jump at TheStreet
10:00AM  Overcoming the 'ick' factor: Why some big names find value in this company at CNBC
09:58AM  Mylan, Allergan shares fall after Perrigo profit warning at MarketWatch
09:53AM  Joseph Papa Resigns As Perrigo CEO, Joins Valeants As Chairman And CEO Benzinga
09:31AM  Stocks to Watch: Perrigo, Valeant, Tribune Publishing, Xerox at The Wall Street Journal
09:30AM  Perrigo shares plunge on weak guidance, CEO resignation at CNBC
09:27AM  Perrigo (PRGO) Stock Tanks as CEO Papa Resigns at TheStreet
08:56AM  Valeant names Joseph Papa as new CEO at MarketWatch
08:46AM  Valeant Names Perrigo's Papa as CEO to Lead Turnaround at Bloomberg
08:38AM  Perrigo Elevates Hendrickson to CEO, Replacing Papa Bloomberg
08:38AM  Perrigo Elevates Hendrickson to CEO, Replacing Papa at Bloomberg
08:38AM  IT'S OFFICIAL: Valeant has a new CEO Business Insider
07:37AM  Perrigo Appoints John T. Hendrickson as Chief Executive Officer, Provides Preliminary First Quarter 2016 Selected Financial Results, and Updates Full Year 2016 Guidance PR Newswire
07:28AM  Exclusive: Perrigo to name Hendrickson CEO as Papa joins Valeant - sources Reuters
Apr-23-16 05:42AM  [$$] Valeants Makeover Is Just Beginning at The Wall Street Journal
Apr-22-16 06:17PM  Still The Greatest Growth Company Wall Street Has Never Heard Of Yahoo Finance Contributors -5.70%
04:04PM  The 52-Week Low Club for Friday at 24/7 Wall St.
03:51PM  Valeants Latest Acquisition Target: Perrigos CEO? at Investor's Business Daily
03:16PM  VRX vs. PRGO for CEO CNBC
03:13PM  Valeant Soars On Reports Perrigo's Papa Will Be New CEO at Barrons.com
02:38PM  The guy who may take over Valeant is walking from crisis to crisis Business Insider
12:50PM  Valeant's Shares Could Rebound if Papa Named New CEO, Analysts Say at TheStreet
Perrigo Company plc, together with its subsidiaries, develops, manufactures, markets, and distributes over-the-counter (OTC) consumer goods and pharmaceutical products worldwide. The company operates through Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences, and Other segments. The CHC segment offers OTC products in various categories, including analgesics, cough/cold/allergy/sinus, gastrointestinal, infant nutritional, smoking cessation, animal health, feminine hygiene, diabetes and dermatological care, diagnostic, scar management, and other healthcare products, as well as vitamins, minerals, and dietary supplements (VMS); and contract manufacturing services. It serves retail drug, supermarket, mass merchandise chains, and wholesalers through sales force and industry brokers. The BCH segment provides branded OTC products in the natural health and VMS; cough, cold, flu, and allergy; personal care and derma-therapeutics; lifestyle; pain relief, nasal decongestants, and cold sore management; and anti-parasite areas, as well as offers generic pharmaceutical products. It serves pharmacies, drug, and grocery stores through pharmacy sales force, as well as a network of pharmacists. The Rx segment offers generic and specialty pharmaceutical prescription drugs in various dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, women's health products, oral solid dosage forms, and oral liquid formulations; and ORx products. It serves wholesalers; retail drug, supermarket, and mass merchandise chains; hospitals; and pharmacies. The Specialty Sciences segment offers Tysabri to treat multiple sclerosis. The Other segment offers active pharmaceutical ingredients used by generic and branded pharmaceutical companies. The company was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brown Judy LExecutive VP & CFOApr 13Option Exercise113.772,776315,82513,924Apr 14 03:38 PM
Brown Judy LExecutive VP & CFOApr 13Sale126.222,776350,38712,429Apr 14 03:38 PM
JANDERNOA MICHAEL JDirectorMar 18Option Exercise16.775,81497,5018,611Mar 22 04:31 PM
JANDERNOA MICHAEL JDirectorMar 18Sale128.2976197,6297,850Mar 22 04:31 PM
Kochan SharonEVP, GM InternationalMar 02Sale125.281,490186,6675,883Mar 04 02:43 PM
Brown Judy LExecutive VP & CFOFeb 24Option Exercise113.772,776315,82513,924Feb 26 03:07 PM
Brown Judy LExecutive VP & CFOFeb 24Sale123.732,776343,47412,429Feb 26 03:07 PM
PERRIGO Co plc10% OwnerFeb 17Buy8.00125,0001,000,0002,908,067Feb 18 05:50 PM
Brown Judy LExecutive VP & CFOJan 06Option Exercise83.1227,7372,305,62426,518Jan 08 03:27 PM
Brown Judy LExecutive VP & CFOJan 06Sale142.4127,7373,950,07512,429Jan 08 03:27 PM
PAPA JOSEPH CCEODec 28Option Exercise58.8210,183598,964129,598Dec 30 03:18 PM
PAPA JOSEPH CCEODec 28Sale147.0710,1831,497,579119,415Dec 30 03:18 PM
Farrington ThomasEVP and CIONov 30Sale151.0335052,8611,194Dec 02 09:29 AM
Gottfried RanDirectorNov 19Option Exercise100.842,726274,89015,454Nov 23 04:17 PM
Gottfried RanDirectorNov 19Sale154.342,726420,72212,728Nov 23 04:17 PM
MORRIS HERMAN JRDirectorNov 18Sale155.6455085,602850Nov 20 07:35 PM
KUNKLE GARY K JRDirectorNov 13Option Exercise146.901,929283,37026,133Nov 17 04:57 PM
JANDERNOA MICHAEL JDirectorNov 13Option Exercise146.901,929283,3702,797Nov 17 04:57 PM
BRLAS LAURIEDirectorNov 13Option Exercise146.901,929283,37010,903Nov 17 04:58 PM
Hoffing Ellen RandiDirectorNov 13Option Exercise146.901,929283,3709,530Nov 17 04:56 PM
FOUSE JACQUALYN ADirectorNov 13Option Exercise146.901,929283,3704,362Nov 17 04:56 PM
COHEN GARY MDirectorNov 13Option Exercise146.901,929283,37013,797Nov 17 04:56 PM
MORRIS HERMAN JRDirectorNov 13Option Exercise146.901,929283,3705,057Nov 17 04:57 PM
O'Connor DonalDirectorNov 13Option Exercise146.901,929283,3702,173Nov 17 04:57 PM
GIBBONS DAVID TDirectorNov 04Option Exercise162.291,929313,05715,104Nov 05 04:16 PM
Gottfried RanDirectorNov 04Option Exercise162.291,929313,05713,654Nov 06 05:22 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyAug 25Sale181.371,737315,0400Aug 27 03:32 PM
KINGMA TODD WExecutive VP, General CounselAug 25Sale181.371,715311,05010,320Aug 27 03:32 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyAug 24Option Exercise114.604,468512,0314,131Aug 25 06:21 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyAug 24Sale177.684,468793,8701,737Aug 25 06:21 PM
Jamison Scott FExecutive Vice President PBMAug 21Option Exercise186.89552103,1635,379Aug 25 06:21 PM
Stewart Michael RobertSr. VP Global Human ResourcesAug 21Option Exercise186.89552103,1631,398Aug 25 06:21 PM
Shah JatinSr VP & Chief Scientific OfficAug 21Option Exercise186.89552103,1634,619Aug 25 06:22 PM
Needham JeffreyEVP, GM Consumer HealthcareAug 21Option Exercise186.89967180,7237,646Aug 25 06:20 PM
Kochan SharonEVP, GM InternationalAug 21Option Exercise186.89967180,7237,731Aug 25 06:20 PM
PAPA JOSEPH CPresident and CEOAug 21Option Exercise186.897,3651,376,445123,234Aug 25 06:21 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyAug 21Option Exercise186.891,022191,0022,223Aug 25 06:21 PM
Farrington ThomasSenior VP and CIOAug 21Option Exercise186.89552103,1631,719Aug 25 06:19 PM
Boothe DouglasEVP & GM Perrigo PharmaAug 21Option Exercise186.8939573,822951Aug 25 06:19 PM
KINGMA TODD WExecutive VP, General CounselAug 21Option Exercise186.891,409263,32812,686Aug 25 06:19 PM
Yu LouisExecutive VP Global QualityAug 21Option Exercise186.89552103,1636,327Aug 25 06:20 PM
Brown Judy LExecutive VP & CFOAug 21Option Exercise186.892,578481,80213,621Aug 25 06:20 PM